The Tres Cantos Open Lab Foundation is offering up to $160,000 for groundbreaking research in the areas of malarial disease, tuberculosis and kinetoplastid diseases.Winners will be able to utilize the facilities and resources of GlaxoSmithKline’s Tres Cantos Medicines Development Campus in Spain. Proposals are due by October 29, 2012. For more information, see the link below:
https://www.innocentive.com/ar/challenge/9933167